Who is sponsoring NCT05735613?

NCT05735613 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05735613?

Interventions in NCT05735613: osteotome crestal sinus lifting, osseodensification crestal sinus lifting, piezoelectric crestal sinus lifting.

What condition does NCT05735613 study?

NCT05735613 studies Maxillary Sinus Augmentation.

Is NCT05735613 still recruiting?

NCT05735613 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT05735613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Different Techniques of Crestal Sinus Lifting

Completed NA Last updated 21 February 2023

What this trial tests

NA trial testing osteotome crestal sinus lifting in Maxillary Sinus Augmentation in 21 participants. Completed in 28 April 2022.

Timeline

15 January 2020

Primary endpoint
30 March 2022

28 April 2022

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	15 January 2020
Primary completion	30 March 2022
Estimated completion	28 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

osteotome crestal sinus lifting
osseodensification crestal sinus lifting
piezoelectric crestal sinus lifting

Conditions studied

Maxillary Sinus Augmentation — all drugs for Maxillary Sinus Augmentation →

Sponsor

Al-Azhar University

Who can join

18 and older, any sex, with Maxillary Sinus Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Twenty one patients with deficient posterior maxilla and alveolar bone height ≤ 5mm were included.Those patients randomly divided into 3 equal groups: 1. Group 1: 7 patients treated by osteotome closed sinus lift with bone grafting (xenograft) and implant placement. 2. Group 2: 7 patients treated by densah burs(Versah, Jackson, MI, USA) sinus lift with bone grafting (xenograft) and implant placement. 3. Group 3: 7 patients treated by piezoelectric (Piezotome; Satelec) crestal sinus lift with bone grafting (xenograft) and implant placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05735613 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing